We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
-14.03%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22.9B
AUM Growth
-$4.32B
Cap. Flow
-$424M
Cap. Flow %
-1.85%
Top 10 Hldgs %
13.89%
Holding
1,428
New
104
Increased
438
Reduced
568
Closed
134

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$499M
2
BMY icon
Bristol-Myers Squibb
BMY
+$59.2M
3
HUM icon
Humana
HUM
+$54.1M
4
EMR icon
Emerson Electric
EMR
+$47.7M
5
TGT icon
Target
TGT
+$45.5M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$68.5M
2
SYK icon
Stryker
SYK
+$50.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$46.2M
4
NVDA icon
NVIDIA
NVDA
+$44.1M
5
SWK icon
Stanley Black & Decker
SWK
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 21.77%
2 Healthcare 16.07%
3 Financials 11.39%
4 Consumer Discretionary 9.78%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MUR icon
501
Murphy Oil
MUR
$5.79B
$6.86M 0.03%
293,202
-195,088
-40% -$5.98M
WCG
502
DELISTED
Wellcare Health Plans, Inc.
WCG
$6.86M 0.03%
29,046
+18,246
+169% +$4.89M
YEXT icon
503
Yext
YEXT
$632M
$6.85M 0.03%
461,406
+74,238
+19% +$1.31M
PM icon
504
Philip Morris
PM
$303B
$6.84M 0.03%
102,411
-2,369
-2% -$198K
AOS icon
505
A.O. Smith
AOS
$7.78B
$6.82M 0.03%
159,602
+40,337
+34% +$1.86M
PGRE
506
DELISTED
Paramount Group
PGRE
$6.81M 0.03%
541,880
+37,100
+7% +$522K
LVS icon
507
Las Vegas Sands
LVS
$26.7B
$6.77M 0.03%
130,142
+27,385
+27% +$1.48M
MIME
508
DELISTED
Mimecast Limited
MIME
$6.73M 0.03%
200,000
+24,000
+14% +$838K
TDOC icon
509
Teladoc Health
TDOC
$1.2B
$6.72M 0.03%
+135,500
New +$8.29M
SHO icon
510
Sunstone Hotel Investors
SHO
$2.05B
$6.7M 0.03%
515,025
+383,900
+293% +$5.65M
HRL icon
511
Hormel Foods
HRL
$11.4B
$6.69M 0.03%
156,827
+71,200
+83% +$3.07M
CPA icon
512
Copa Holdings
CPA
$5.13B
$6.68M 0.03%
84,910
-32,735
-28% -$2.56M
PNW icon
513
Pinnacle West Capital
PNW
$11.5B
$6.68M 0.03%
78,416
+19,000
+32% +$1.64M
WCN
514
Waste Connections
WCN
$40.1B
$6.63M 0.03%
89,258
+23,792
+36% +$1.81M
NTR icon
515
Nutrien
NTR
$37.6B
$6.62M 0.03%
140,924
ARRY
516
DELISTED
Array Biopharma Inc
ARRY
$6.58M 0.03%
461,486
VOT icon
517
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$18.8B
$6.55M 0.03%
54,700
+7,200
+15% +$925K
OKTA icon
518
Okta
OKTA
$33.3B
$6.54M 0.03%
102,588
+6,200
+6% +$367K
MOS icon
519
The Mosaic Company
MOS
$8.09B
$6.54M 0.03%
223,937
-511,600
-70% -$16.8M
STML
520
DELISTED
Stemline Therapeutics, Inc.
STML
$6.47M 0.03%
681,478
+229,490
+51% +$2.98M
GEF icon
521
Greif
GEF
$4.63B
$6.47M 0.03%
174,400
-10,900
-6% -$510K
FTS icon
522
Fortis
FTS
$27.3B
$6.46M 0.03%
193,708
-142,441
-42% -$4.79M
FXI icon
523
iShares China Large-Cap ETF
FXI
$4.1B
$6.45M 0.03%
165,115
+3,500
+2% +$141K
CE icon
524
Celanese
CE
$5.18B
$6.31M 0.03%
70,094
-700
-1% -$68.6K
DHC
525
Diversified Healthcare Trust
DHC
$1.89B
$6.28M 0.03%
535,668
-81,400
-13% -$1.21M

Similar funds

Axa's Q4 2018 Portfolio in Review

As of Q4 2018, Axa held 1,428 positions worth $22.9B, down 16% from $27.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q4 2018 filing shows 104 new, 438 increased, 568 reduced and 134 closed positions. Its largest new stake was Linde: 3,157,617 shares worth $493M. The largest sale was Hologic, an estimated $68.5M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2018 buy was Linde: 3,157,617 shares worth $493M.
  • Axa added most to Bristol-Myers Squibb in Q4 2018, an estimated $59.2M increase.
  • Axa's biggest Q4 2018 reduction was Hologic, cutting an estimated $68.5M.
  • Axa fully exited Praxair Inc in Q4 2018, selling an estimated $25.6M.
  • Axa's ten largest holdings make up 14% of its $22.9B portfolio in Q4 2018.
  • Axa opened 104 new positions and closed 134 in Q4 2018.
  • Axa's portfolio value fell 16% quarter-over-quarter to $22.9B.

Based on Axa's 13F filing for Q4 2018, filed 13 Feb 2019.